US 9382311
HIV-1 broadly neutralizing antibodies
granted A61KA61K2039/505A61K39/42
Quick answer
US patent 9382311 (HIV-1 broadly neutralizing antibodies) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K39/42, A61K45/06, A61P